🇨🇦 Haemophilus Influenza type b vaccine in Canada

Haemophilus Influenza type b vaccine (Haemophilus Influenza type b vaccine) regulatory status in Canada.

Marketing authorisation

Haemophilus Influenza type b vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Haemophilus Influenza type b vaccine approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Haemophilus Influenza type b vaccine in Canada?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.